172 related articles for article (PubMed ID: 1566298)
1. Fulminant hepatitis in an Italian infant with visceral leishmaniasis.
di Martino L; Vajro P; Nocerino A; Scotti S; Napolitano G; Vegnente A
Trans R Soc Trop Med Hyg; 1992; 86(1):34. PubMed ID: 1566298
[No Abstract] [Full Text] [Related]
2. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
[No Abstract] [Full Text] [Related]
3. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Kuyucu N; Kara C; Bakirtaç A; Teziç T
Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
[TBL] [Abstract][Full Text] [Related]
4. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
[No Abstract] [Full Text] [Related]
5. Chemotherapy of leishmaniasis in India.
Thakur CP
Indian J Pediatr; 1987; 54(1):7-10. PubMed ID: 3030933
[No Abstract] [Full Text] [Related]
6. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM
J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
[TBL] [Abstract][Full Text] [Related]
7. Visceral leishmaniasis in a patient with human immunodeficiency virus.
Rizzi M; Arici C; Bonaccorso C; Gavazzeni G
Trans R Soc Trop Med Hyg; 1988; 82(4):565. PubMed ID: 3256108
[No Abstract] [Full Text] [Related]
8. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
9. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
Verdejo J; Alvar J; Polo RM; González-Lahoz JM
Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
[No Abstract] [Full Text] [Related]
10. Kala azar with disseminated dermal leishmaniasis.
Kumar PV; Sadeghi E; Torabi S
Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
[TBL] [Abstract][Full Text] [Related]
11. [Visceral leishmaniasis with cardiac affectation in an immunocompetent patient].
Puerto-Alonso JL; Molina-Ruano FJ; Gómez-Soto F; Gómez-Rodríguez F
Med Clin (Barc); 2006 Oct; 127(13):519. PubMed ID: 17043012
[No Abstract] [Full Text] [Related]
12. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL
Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619
[TBL] [Abstract][Full Text] [Related]
13. Severe leucopenia during treatment of visceral leishmaniasis.
Hiçsönmez G; Jama H; Ozsoylu S
Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
[No Abstract] [Full Text] [Related]
14. Pseudo-acute transformation of an idiopathic myelofibrosis due to kala-azar.
Disdier P; Swiader L; Serratrice J; Mary C; Weiller PJ
Br J Haematol; 1998 Feb; 100(2):449. PubMed ID: 9488642
[No Abstract] [Full Text] [Related]
15. [Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
Ribelles N; Casals A; Vallés J; Clotet B
Med Clin (Barc); 1989 May; 92(17):679. PubMed ID: 2747338
[No Abstract] [Full Text] [Related]
16. Visceral leishmaniasis in a Brazilian child infected perinatally with human immunodeficiency virus.
Ferreira E; Lucena S; Fonseca G; Barbosa TC; Aquino RB; Lambert JS; Nogueira SA
Pediatr Infect Dis J; 2001 Feb; 20(2):224-6. PubMed ID: 11224850
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis.
da Silva SM; Amorim IF; Ribeiro RR; Azevedo EG; Demicheli C; Melo MN; Tafuri WL; Gontijo NF; Michalick MS; Frézard F
Antimicrob Agents Chemother; 2012 Jun; 56(6):2858-67. PubMed ID: 22411610
[TBL] [Abstract][Full Text] [Related]
18. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
Utili R; Rambaldi A; Tripodi MF; Andreana A
Infection; 1995; 23(3):182-3. PubMed ID: 7499009
[TBL] [Abstract][Full Text] [Related]
19. Treatment of kala azar.
Ozsoylu S
Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
[No Abstract] [Full Text] [Related]
20. [Spontaneous rupture of the spleen in a patient with visceral leishmaniasis].
Rovira RE; Díaz-Gómez JR; Lapuebla X; Aguar MC
Enferm Infecc Microbiol Clin; 2005 May; 23(5):327. PubMed ID: 15899186
[No Abstract] [Full Text] [Related]
[Next] [New Search]